PTHS
AMEX · Biotechnology
Pelthos Therapeutics Inc
$8.99
-0.40 (-4.26%)
Open$9.46
Previous Close$9.39
Day High$9.46
Day Low$8.82
52W High$37.40
52W Low$7.79
Volume—
Avg Volume76.9K
Market Cap31.57M
P/E Ratio—
EPS$-21.82
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+203.4% upside
Current
$8.99
$8.99
Target
$27.28
$27.28
$18.57
$27.28 avg
$35.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 31.37M | 12.22M | 12.16M |
| Net Income | -80,901,337 | 1.67M | 1.59M |
| Profit Margin | -257.9% | 13.7% | 13.1% |
| EBITDA | -58,191,549 | 2.79M | 3.00M |
| Free Cash Flow | — | 1.30M | 1.27M |
| Rev Growth | — | +12.4% | +20.7% |
| Debt/Equity | 0.81 | 0.63 | 0.63 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |